After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CRNX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Crinetics Pharmaceuticals Inc is $3.19B. A total of 1.0 million shares were traded on the day, compared to an average of 971.70K shares.
In the most recent transaction, Pizzuti Dana sold 5,000 shares of CRNX for 39.07 per share on Feb 03 ’25. After the transaction, the Chief Med and Dev Officer now owns 31,748 company shares. In a previous transaction on Feb 03 ’25, DANA J PIZZUTI bought 5,000 shares at 39.07 per share.
Among the insiders who sold shares, Pizzuti Dana disposed of 15,000 shares on Jan 03 ’25 at a per-share price of $52.09. This resulted in the Chief Med and Dev Officer holding 29,248 shares of CRNX after the transaction. In another insider transaction, DANA J PIZZUTI bought 15,000 shares at $52.09 per share on Jan 03 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CRNX has a high of $62.53 and a low of $31.84.
As of this writing, CRNX has an earnings estimate of -$0.94 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.56 per share and a lower estimate of -$1.08.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CRNX’s latest balance sheet shows that the firm has $333.71M in Cash & Short Term Investments as of fiscal 2021. There were $3.07M in debt and $15.99M in liabilities at the time. Its Book Value Per Share was $14.26, while its Total Shareholder’s Equity was $331.94M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRNX is Buy with a score of 4.87.
